Latest news
NewAmsterdam Pharma grants 28,000 inducement share options at $27.79 to new hires - BitgetBitget · Thu, 06 Aug 2026 20:27:02 GMTThree New Hires Receive Stock Awards With Up to 4-Year Vesting - Stock TitanStock Titan · Thu, 06 Aug 2026 20:01:00 GMTNewAmsterdam Pharma Wins CHMP Opinion for Obicetrapib Cholesterol Drug - The Clinical Trial VanguardThe Clinical Trial Vanguard · Thu, 06 Aug 2026 06:43:58 GMTNewAmsterdam Pharma Company N.V. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.commarketscreener.com · Wed, 05 Aug 2026 15:53:29 GMTNewAmsterdam Pharma Company N.V. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Wed, 05 Aug 2026 12:46:24 GMTNewAmsterdam Pharma reports $3.7 million second quarter revenue - Quiver QuantitativeQuiver Quantitative · Wed, 05 Aug 2026 11:16:00 GMTNewAmsterdam reports $64.1M Q2 net loss, $678.3M cash; CHMP recommends obicetrapib approval - TradingViewTradingView · Wed, 05 Aug 2026 11:13:00 GMTNewAmsterdam Pharma Co N.V. Q2 2026: Revenue $3.7M, EPS $(0.52) — 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 11:11:01 GMT